The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
The facility has the capacity to produce one crore doses per day
Agilent Technologies Inc. announced the contribution of Agilent AriaMx Real-Time qPCR instruments to five research hospitals in India to support their COVID-19 initiatives and help them serve the community at large
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
Anti-malaria API facility will be operational in 15-18 months
CDSCO to fast-track trials and approval for COVID19 vaccine
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
Subscribe To Our Newsletter & Stay Updated
